News Focus
News Focus
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 18972

Tuesday, 07/30/2019 8:16:40 AM

Tuesday, July 30, 2019 8:16:40 AM

Post# of 30495
MRK 2Q19 results—Keytruda sales +63% YoY in constant currency.

2019 non-GAAP EPS guidance raised to $4.84-4.94 (from old range of $4.67-4.79). The midpoint of the new range represents 13% growth relative to 2018.

PR:
https://s21.q4cdn.com/488056881/files/doc_financials/2019/Q2/Merck-News-Release-07-30-19-Merck-Announces-Second-Quarter-2019-Financial-Results.pdf

CC slides:
https://s21.q4cdn.com/488056881/files/doc_financials/2019/Q2/Q219-Earnings-Deck_MRK.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today